Establishment Labs Holdings Inc. announced the appointment of Taylor Harris to its Board of Directors, effective June 24, 2026. Mr. Harris will serve until the 2027 annual meeting and will join the Audit Committee and the Nominating and Corporate Governance Committee. The company's non-employee director compensation policy, updated in April 2026, provides for an initial equity grant of $170,000 for new directors. Establishment Labs Holdings Inc. operates in the medical aesthetics industry, providing breast implants and related products.